Луциус Мирдаметиниб – Купить онлайн
Луциус Мирдаметиниб – Купить онлайн

Луциус Мирдаметиниб – Купить онлайн

EUR 563.29

1,500+ vendidos
Preco promocional

Farmacia fisica em Hong Kong, 100% de autenticidade garantida

Destaques do produto

(Mirdametinib) MEK1 MEK2 ，

Garantias de servico

Envio direto internacionalFarmacia autorizadaRevisado por farmaceuticoGarantia de autenticidade

Especificacoes

Especificacao
1mg*42 capsulas/caixa
Fabricante
Lucius Pharmaceuticals
Envio
Hong Kong

10000 em stock

Categoria: Marca:

Informacoes do produto

Nome em ingles
Mirdametinib
Nome generico
Mirdametinib

Especificacoes

Especificacao
1mg*42 capsulas/caixa
Fabricante
Lucius Pharmaceuticals
Envio
Hong Kong

Detalhes completos

Indicacoes

Mirdametinib is the first and only therapy approved in the European Union for adults and children 2 years of age and older with neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN).

Mecanismo de acao

Mirdametinib Como funciona Como funciona ，

Dosagem

2 GOMEKLI 2 mg/m²， ， ， 28 21 GOMEKLI (2) 2.1 GOMEKLI GOMEKLI [ Precaucoes (5.1)] (EF)[ Precaucoes (5.2)] 2.2 GOMEKLI GOMEKLI GOMEKLI ，

Precaucoes

5 Precaucoes GOMEKLI ， ， ， ， GOMEKLI (5.1) GOMEKLI ， ， 3 ， GOMEKLI (5.2) ， ， GOMEKLI

Package Insert

Ingredients

11 GOMEKLI (R)-N-(2,3- )-3,4- -2-((2- -4- ) ) C16H14F3IN2O4， 482.20 g/mol ， 25°C 0.25 mg/mL，pH 7.2 pKa 7.96

Indications

Mirdametinib is the first and only therapy approved in the European Union for adults and children 2 years of age and older with neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN).

Dosagem

2 GOMEKLI 2 mg/m²， ， ， 28 21 GOMEKLI (2) 2.1 GOMEKLI GOMEKLI [ Precaucoes (5.1)] (EF)[ Precaucoes (5.2)] 2.2 GOMEKLI GOMEKLI GOMEKLI ，

Precautions

5 Precaucoes GOMEKLI ， ， ， ， GOMEKLI (5.1) GOMEKLI ， ， 3 ， GOMEKLI (5.2) ， ， GOMEKLI

Use in Pregnancy and Lactation

8.1 Como funciona[ (12.1)] ，GOMEKLI - ， mirdametinib， - ， (BSA) 2 mg/m²， ， 2% 4% 15% 20%

Clinical Pharmacology

12 12.1 Como funciona 1 2 (MEK1/2) MEK1/2 (ERK) ， MEK1 MEK2 ERK NF1 ， ERK ， 12.2 -

Pharmacology and Toxicology

13 13.1 6 rasH2 ， 5 mg/kg AUC ， 2 mg/m² 15 Ames ， 1 ， 28

Clinical Studies

6.1 ， ， Precaucoes Descrição ReNeu [ (14)] n=114 NF-106 n=19 [NCT-02096471] 133 75 58 GOMEKLI 28 21 GOMEKLI 2 mg/m²， ， GOMEKLI 133 ，62% ，38% ，12%

Avaliacoes do produto (17)

Filtro: Todas as avaliacoes
4.8★★★★★
17 avaliacoes de clientes14 compras verificadas
+o***e· 3周前
★★★★
+t***3· 1个月前
Compra verificada
★★★★★

Descricao

Indicacoes

Mirdametinib is the first and only therapy approved in the European Union for adults and children 2 years of age and older with neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN).

Mecanismo de acao

Mirdametinib Como funciona Como funciona ，

Dosagem

2 GOMEKLI 2 mg/m²， ， ， 28 21 GOMEKLI (2) 2.1 GOMEKLI GOMEKLI [ Precaucoes (5.1)] (EF)[ Precaucoes (5.2)] 2.2 GOMEKLI GOMEKLI GOMEKLI ，

Precaucoes

5 Precaucoes GOMEKLI ， ， ， ， GOMEKLI (5.1) GOMEKLI ， ， 3 ， GOMEKLI (5.2) ， ， GOMEKLI